GWAS |
- Asthma (childhood onset) ( 31036433)
- Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) ( 26974007)
- Crohn's disease ( 28067908)
- Inflammatory bowel disease ( 28067908)
- Lymphocyte counts ( 27863252)
- Psychosis in Alzheimer's disease ( 22005930)
|
- Bladder cancer ( 24163127 20972438)
- Blood metabolite levels ( 24816252)
- Blood metabolite ratios ( 24816252)
- Cholesterol, total ( 24097068 20686565)
- Coronary artery disease ( 29212778)
- Insulin resistance/response ( 25798622)
- Iron status biomarkers (transferrin levels) ( 25352340)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Liver injury in anti-tuberculosis drug treatment ( 31109976)
- Medication use (calcium channel blockers) ( 31015401)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Metabolic syndrome ( 31589552)
- Metabolic traits ( 21886157)
- Metabolite levels ( 23823483)
- Night sleep phenotypes ( 27126917)
- Paclitaxel-induced neuropathy ( 23776197)
- Total cholesterol levels ( 28334899)
- Triglyceride levels ( 28334899 29403010 30698716)
- Triglyceride levels in current drinkers ( 30698716)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x long total sleep time interaction (2df test) ( 31719535)
- Triglyceride levels x short total sleep time interaction (2df test) ( 31719535)
- Triglycerides ( 24097068 20686565)
- Urinary metabolite levels in chronic kidney disease ( 31959995)
- Urinary metabolite modules (eigenmetabolites) in chronic kidney disease ( 31959995)
- Urinary metabolites ( 26352407 21572414)
- Urinary metabolites (H-NMR features) ( 24586186)
|